Jian Wu
Sun Yat-sen University(CN)China University of Geosciences(CN)Ganzhou People's Hospital(CN)Xianning Central Hospital(CN)The First Affiliated Hospital, Sun Yat-sen University(CN)First Affiliated Hospital Zhejiang University(CN)Hubei University(CN)Zhejiang University(CN)
Publications by Year
Research Areas
MicroRNA in disease regulation, Cancer-related molecular mechanisms research, Hepatocellular Carcinoma Treatment and Prognosis, Organ Transplantation Techniques and Outcomes, RNA modifications and cancer
Most-Cited Works
- → Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study(2021)1,051 cited
- → WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1(2019)663 cited
- → Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial(2020)556 cited
- → Liver Transplantation for Hepatocellular Carcinoma(2008)455 cited
- → Amino acid metabolism in health and disease(2023)444 cited
- → Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial(2021)391 cited